In situ hybridization

From Food & Medicine Encyclopedia

In situ hybridization (ISH) is a type of hybridization that uses a labeled complementary DNA, RNA or modified nucleic acids strand (i.e., probe) to localize a specific DNA or RNA sequence in a portion or section of tissue (in situ), or, if the tissue is small enough (e.g., plant seeds, Drosophila embryos), in the entire tissue (whole mount ISH), in cells, and in circulating tumor cells (CTCs). This is distinct from immunohistochemistry, which usually localizes proteins in tissue sections.

Procedure[edit]

The procedure of in situ hybridization comprises the following steps:

  1. Fixation of tissue section or cells onto a glass slide
  2. Pre-hybridization treatment to increase accessibility of target DNA or RNA
  3. Hybridization of the probe to the DNA or RNA target
  4. Stringent washes to remove excess probe
  5. Detection of the hybridized probe
  6. Visualization of the target molecule

Applications[edit]

In situ hybridization is used in many areas of research and diagnosis including:

  1. Developmental biology
  2. Cancer and other disease diagnosis
  3. Genetics
  4. Evolutionary biology

Types of In Situ Hybridization[edit]

There are two types of in situ hybridization:

  1. Fluorescent in situ hybridization (FISH)
  2. Chromogenic in situ hybridization (CISH)

Fluorescent In Situ Hybridization (FISH)[edit]

Fluorescent in situ hybridization (FISH) is a molecular cytogenetic technique that uses fluorescent probes that bind to only those parts of the chromosome with a high degree of sequence complementarity.

Chromogenic In Situ Hybridization (CISH)[edit]

Chromogenic in situ hybridization (CISH) is a molecular technique that allows the visualization of specific genes or gene fragments in tissues.

See Also[edit]

This article is a medical stub. You can help WikiMD by expanding it!
PubMed
Wikipedia
Navigation: Wellness - Encyclopedia - Health topics - Disease Index‏‎ - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes

Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

W8MD's happy loser(weight)

Tired of being overweight?

Special offer:

Budget GLP-1 weight loss medications

  • Semaglutide starting from $29.99/week and up with insurance for visit of $59.99 and up per week self pay.
  • Tirzepatide starting from $45.00/week and up (dose dependent) or $69.99/week and up self pay

✔ Same-week appointments, evenings & weekends ✔ Tele visits available with certain limitations Learn more:

Advertise on WikiMD


WikiMD Medical Encyclopedia

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.